Merck's $17 billion acquisition of sigma Aldrich
-
Last Update: 2014-09-23
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: Tencent finance 2014-09-23 Beijing time on the afternoon of September 22, 2014, the pharmaceutical industry reappeared large-scale M & A Merck KGaA, a German industry giant, announced on Monday that it would purchase sigma Aldrich pharmaceutical company for $17 billion The deal will expand MSD's life sciences business Merck's offer for Aldrich is $140 a share in cash, valuing him at $17 billion (13.1 billion euros) The price is 37% higher than the closing price of $102.37 per share on Friday, September 19, and 36% higher than the average closing price of last month The acquisition will immediately have a positive impact on the company's current earnings per share and EBITDA margin, Mr moshadong said MSD expects to save at least 260 million euros (US $340 million) per year through restructuring in the next three years after the completion of the acquisition MSD expects that the acquisition will be completed in mid-2015, and the acquisition process mainly depends on the approval of the regulatory authorities, the approval of the special shareholders' meeting held by Aldrich and other practices (Xiao He)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.